Thiazoles used as fungicides 机翻标题: 暂无翻译,请尝试点击翻译按钮。

公开号/公开日
WO2007033780 A2 2007-03-29 [WO200733780]WO2007033780 A3 2007-10-11 [WO200733780] / 2007-03-292007-10-11
申请号/申请日
2006WO-EP08861 / 2006-09-12
发明人
GREUL JOERG NICO;GAERTZEN OLIVER;DUNKEL RALF;GUTH OLIVER;HILLEBRAND STEFAN;ILG KERSTIN;SCHREIER PETER;WACHENDORFF-NEUMANN ULRIKE;DAHMEN PETER;VOERSTE ARND;HADANO HIROYUKI;
申请人
BAYER CROPSCIENCE;
主分类号
IPC分类号
A01N-043/78A01P-003/00C07D-417/04C07D-417/14
摘要
(WO200733780) Disclosed is the use of compounds of formula (I), wherein R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>5</SUP>, R<SUP>6</SUP>, R<SUP>7</SUP>, R<SUP>8</SUP> as well as X, Y, Z have the meanings indicated in the description, as fungicides.  Also disclosed are compounds of formula (Ia), wherein R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>5</SUP>, R<SUP>6</SUP>, R<SUP>7</SUP>, R<SUP>8</SUP>, R<SUP>14</SUP>, A, X, Y, and Z have the meanings indicated in the description, methods for producing said substances, and the use thereof for controlling undesired microorganisms.
机翻摘要
暂无翻译结果,您可以尝试点击头部的翻译按钮。
地址
代理人
代理机构
;
优先权号
2005DE-10045722 2005-09-24 2005DE-10048072 2005-10-07
主权利要求
(WO200733780) Claims 1. Use of compounds of formula (I),  in which the symbols have the following meanings: R1to R4are independently hydrogen, halogen, Cyano, hydroxy, Nitro, Or1,1, SR11, SOR11, SO2R11, SO2N (Rn)2) C=OR11, nr11coor12, N (Rπ)2, nr11cor11, nr11cor12, nr11SO2R12, ocon (R1%, OC=OR11, con (RU)2, coor11, (ch2)mOrn, (ch2)mSRu, ( CHz)1nN (R11^, (ch2)mcoor12, ( CHz)111nr11coor11, unsubstituted Or substituted CrC8- alkyl, d-cg-Haloalkyl, C3- C8- cycloalkyl; with m=1 - 8 or in each case two adjacent radicals R1, R2or R2, R3or R3, R8or R8, R4together form an unsubstituted or substituted, five - or six - membered heterocyclic ring. R5is hydrogen, unsubstituted or substituted ci-C8- alkyl, unsubstituted or substituted ci-C4- Alkylc (O=), C1- C4- Alkyloc (O=), unsubstituted or substituted unsubstituted or substituted C2- C6- alkenyl, unsubstituted or substituted C2- C6- alkynyl, ci-C6- Alkylsulfinyl, ci-Cβ-Alkylsulfonyl, C3- C8- cycloalkyl; ci-C6- haloalkyl, ci-C4- halogenoalkylsulfinyl, CrC4- haloalkylsulfonyl, halo-C1- C4- alkoxy-ci-C4- alkyl, C3- C8- halocycloalkyl having in each case 1 to 9 - fluorine, chloro - and/or bromine atoms; Formyl, Formyl-ci-C3- alkyl, (ci-C3- alkyl) carbonyl-ci-C3- alkyl, (C, - C3- alkoxy) carbonyl-ci-C3- alkyl; halogen - (CrC3- alkyl) carbonyl-C, - C3- alkyl, Halogen - (ci-C3- alkoxy) carbonyl-ci-C3- alkyl having in each case 1 to 13 fluorine -, chlorine - and/or bromine atoms; (CrC8- alkyl) carbonyl, (ci-Q-alkoxy) carbonyl, (ci-cg-Alkylthio) carbonyl, (ci-C4- alkoxy-CrC4- alkyl) carbonyl, (C3- C6- Alkenyloxy) carbonyl, (C3- C6- alkynyl - oxy) carbonyl, (C3- C8- cycloalkyl) carbonyl; (ci-coe- Halogenalkytycarbonyl, (CrC6- halo - Alkylthio) carbonyl, (ci-C6- haloalkoxy) carbonyl, (C3- C6halogen - Alkenyloxy) carbonyl, (C3- C6- alkynyloxy halogen) carbonyl, (halo-C1- C4- alkoxy-CrC4- alkyl) carbonyl, (C3- C8- halocycloalkyl) carbonyl having in each case 1 to 9 fluoro - -, chloro - and/or bromine atoms, or - ch2C - - R ≡ €I A, - ch2- ch=ch-RI A, - CH=C=ch-R1 A, - C (=O) C (=O) R2, - conr3R4, - ch2Nr5R6, CrC4- Trialkyl-Silyl or CrC4- Dialkyl-Mono-phenyl-Silyl, RI Ais hydrogen, C1- C6 AIlCyI-, C, C -6- haloalkyl, C2- C6- alkenyl, Q-Q-alkynyl, C3- C7- cycloalkyl, (ci-C4- alkoxy) carbonyl, (C3- C6- Alkenyloxy) carbonyl, (C3- C6- alkynyloxy) - carbonyl or cyano, X is nitrogen or CR8 Y is nitrogen or CR9 Z is nitrogen or CR10 R6is hydrogen, halogen, cyano, hydroxy, Or11, Sr11, cor11, CO2R11, unsubstituted Or substituted CrC8- alkyl, Q-cg Haloalkyl, CrC4- Trialkyl-Silyl, N (RU)2, NR11COR11, NR11COR12, NR11SOnR11, C0N (Rπ)2, C3- C8- cycloalkyl, aryl, Hetaryl; with n=0 - 2 R7is hydrogen, halogen, cyano, hydroxy, amino, N (Rn)2, nitro, Or11, Sr11, unsubstituted Or substituted ci-cg-alkyl, unsubstituted Or substituted C3- C6- cycloalkyl, crc4- Trialkyl-Silyl, coor1\ con (R1% cor1' or R7and R10together form a saturated or unsaturated bridge of the following structure:  with R13=independently of one another hydrogen, halogen, unsubstituted or substituted Q - C3- alkyl, unsubstituted or substituted d-C3- alkoxy or two residues R continuous geminally13represent doubly attached oxygen or sulphur. R8is hydrogen, halogen, Cyano, hydroxy, nitro, Or11, Sr11, sor11, SO2R11, SO2N (RU)2, C=OR11, NR11COOR12, N (Rπ)2, NR11COR11, NR11COR12, NR11SO2R12, 0C0N (Ru)2, OC=OR11, CON (R11^ COor ", (CH2)mOR1!, (CH2)mSru, (CH7) ^ N (R11), (CH2)mCOor12: (CH2)mNR11COOR11, unsubstituted or substituted CrC8- alkyl, CrC8- Haloalkyl, C3- cg-cycloalkyl; with m=1 - 8 R9is hydrogen, halogen, N (Rn)2, cyano, hydroxy, Or11, Sr11, cor11, unsubstituted Or substituted Q-cg-alkyl Or unsubstituted Or substituted C3- C8- cycloalkyl R10is hydrogen, halogen, cyano, hydroxy, amino, N (R11^ nitro, Or11, Sr11, unsubstituted Or substituted CrCgalkyl, C, C -4- Trialkyl-Silyl, coor11, con (RU)2 R11is the same or different and are hydrogen, unsubstituted or substituted ci-C8- alkyl, C-Q-Haloalkyl, CrC4- Trialkyl-Silyl, aryl, or in the case, the two radicals R11bound to a nitrogen atom, two radicals R117-membered 3 to a, unsubstituted or substituted, saturated or unsaturated cycle, up to five further heteroatoms, selected from N, O and S may contain, where two oxygen atoms are not adjacent, form. or in the case, the two radicals R11adjacent in the grouping Nr11COr11are present, two radicals R117-membered 3 to a, unsubstituted or substituted, saturated or unsaturated cycle, up to five further heteroatoms, selected from N, O and S may contain, where two oxygen atoms are not adjacent, form. R12is the same Or different unsubstituted Or substituted CrC8- alkyl, ci-C8- Haloalkyl, (ch2)pOrπ, C-Q-Trialkyl Silyl; with p=1 - 4 and agrochemically active salts thereof as fungicides. 2. Use of compounds of formula (I) in which one or more of the symbols have the meanings listed below a: R1to R4are independently hydrogen, fluorine, chlorine, bromine, iodine, Cyano, Hydroxy, nitro, OR11, O - Me, - Et O, O - Pr, O - / Pr, Bu O -, O - secBu, O - woBu, O - / Bu, - O (CH2)2oh, O - (CH2)2och3, O - (CH2)3oh, O - (CH2)3och3, ocf3, SR11, SH, S - Me, - Et S, spr, S - Zpr, - S Bu, S - secBu, S - Zsobu, S - Zbu, scf3, sor11, so - Me, - Et-so, so - Pr, - Zpr so, so - Bu, - so secBu, so - Zsobu, so - Zbu, so2R11, so2- Me, so2- Et, so2- Pr, so2- Zpr, so2- Bu, so2- yecBu., so2ώ - obu, so2- Jbu, son (R1^2, SONHMe, SONMe2, SONHEt, sonet2, SONHPr, SONPr2, SONHBu, SONBu2, SONHCF3, son (CF3)2, so2N (R1^2, so2nhme, so2nme2, so2net2, so2nhet, so2npr2, so2nhpr, so2 NHCF3, so2N (CF3), Cor11, Come, COEt, copr, COiPr, COBu, COsecBu, CO- Wobu, COfBu, COCF3, NR11CO2R11, NR11CO2Me, NR11CO2Et, NR11CO2Pr, NR11CO2Zpr, NR11CO2Bu, NR11CO2 secBu, NR11CO2 Wobu, NR11CO2 Zbu, NR11cor11, NHcome, NHcoet, NHcopr, NHco/Pr, NHCOBu, NHCOiBu, NHCOsecBu, NHCOZsoBu, NHCOZBu, NHco (CH2)2OH, NHco (CH2)2Och3, NHco (CH2)3OH, NHco (CH2)3Och3, NR11come, NR11 COEt, NR11copr, NR11 COZPr, NR11 COBu, NR11CO ^ Ru, NR11 COzBu, NR11CO (CH2)ZOH, NR11CO (CH2)ZOch3, NR11CO ( CHz)3OH, NRUCO (CH2)3Och3, N (R1% nme2, net2, nhme, nh2, NHzBu, nhet, nhpr, NHZPr, NHBu, NHzBu, NHsecBu, piperazine 1-yl, 4 - methylpiperazine-1-yl, Moφholin-1-yl, NR11SO2R12, NHSOR11, NR11sor11, NHSOMe, NHSO2Me, NHSOEt, NHSO2Et, NMeSOMe, NHSO2R11, NR11SO2R11, NMeSO2Me,  NMeSOEt, NMeSO2Et, NHSOCF3, NHSO2CF3, OCON (R11)2, OCONHMe, OCONHEt, OCONHPr, OCONHZPr, OCONHBu, OCONHsecBu, OCONHZsoBu, OCONHzBu, OCONMe2, OCONEt2, OCONPr2, OCONZPr2, OCONBu2, OCONsecBu2,  OCONHZBu2, OCOR11, OCOMe, OCOEt, OCOPr, OCOZPr, OCOBu, OCOsecBu, OCOZsoBu, OCOZBu, CON (R1% conhet, conet2, conhme, conme2, CONHPr,  CONPr2, CONHBu, CONHsecBu, CONHZsoBu, CONHzBu, CONHCH (CH3) CH2OH, CONHCH (CH3) CH2Och3, CONHCH (C2H5) CH2OH, CONHCH (C2H5) CH2Och3, conh (CH2)2Och3, conh (CH2)2OH, conh (CH2)3Och3, conh (CH2)3OH, conr11CH (CH3) CH2OH, conr11CH (CH3) CH2Och3, conr11CH (C2H5) CH2OH, conr11CH (C2H5) CH2Och3, conr1^ CHZ)2Och3, conr1^ CHZ)2OH, CONR1^ CHJ)3Och3, CONR1 CHz^)3OH, CO2R11, CO2Me, CO2Et, CO2Pr, CO2Zpr, CO2Bu, CO2 SeCBu, CO2 Zsobu, CO2 Zbu, CO2(CH2)2OH, CO2(CH2)2Och3, CO2(CH2)3OH, CO2( CHz)3Och3, (CH2)mOrπ, CH2OH, (CH2)2OH, (CH2)3OH, (CH2)4OH, CH2Ome, (CH2)2Ome, (CH2)3Ome, (CH2)4Ome, (CH2)mSrπ, CH2SH, (CH2)2SH, (CH2)3SH, (CH2)4SH, CH2Sme, (CH2)2Sme, (CH2)3Sme, (CH2)4Sme, ( CHz)1nN (R1^2, CH2nh2, CH2nac2, CH2N ( COCF3)Z, CH2nhac, CH2nhcocf3, (CH2)2nh2, (CH2)3nh2, ( CHz)4nh2, CH2nme2, (CH2)2nhme, (CH2)2nme2, (CH2)3nhme, (CH2)3nme2, (CH2)4nhme, (CH2)4nme2, (CH2)mCOOR12, CH2COOMe, (CH2)2COOMe, (CH2)3COOMe, CH2COOEt, (CH2)2COOEt, (CH2)3COOEt, CH2COOPr, (CH2)2COOPr, (CH2)3COOPr, CH2 COOZPr, (CH2)2 COOZPr, (CH2)3 COOZPr, CH2 COOzBu, (CH2) zCOO/Bu, (CHZ)3 COOZBU, CH2COO (CH2)2OH CH2COO (CH2)2Och3, CH2COO ( CHz)3OH, CH2COO (CHZ)3Och3, CH2nhcoor11, CH2NR11coor11, CH2nhcoome, CH2 NHcoofbu, CH2 NHCOOEt, CH2 NHCOOPr, CH2 NHCOOZPr, CH2 NHcoobu, CH2 NHcoofbu, CH2 NHcoose1u, CH2 NHcoowobu:CH2NR11cooet, CH2NR11coopr, CH2NR11 COOiPr, CH2NR11 COOBu, CH2NR11 COOfBu, CH2NR11 COOsecBu, methyl, ethyl, propyl, 1-Methylethyl, butyl, 1 - Methyl-propyl, 2-Methylpropyl, 1.1-Dimethylethyl, pentyl, 1-Methylbutyl, 2-Methylbutyl, 3-Methylbutyl, 2.2-Di-methyl-propyl, 1-Ethylpropyl, hexyl, 1.1-dimethylpropyl, 1.2 - dimethylpropyl, 1-Methylpentyl, 2-Methylpentyl, 3-Methylpentyl, 4-Methylpentyl, 1.1 - dimethylbutyl, 1.2-dimethylbutyl, 1.3-dimethylbutyl, 2.2-dimethylbutyl, 2.3 - dimethylbutyl, 3.3-dimethylbutyl, 1-Ethylbutyl, 2-Ethylbutyl, 1, 1, 2- Trimethylpropyl, 1, 2, 2- Trimethylpropyl, 1 - ethyl - 1-methyl propyl and l-ethyl-2-methyl propyl; cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl; CF3, CF2H, ccl3, C2F5, C3F7, CF (CF3)2 in each case two adjacent radicals R1, R2or R2, R3or R3, R8or R8, R4together form an unsubstituted or 1 to 4 halogen atoms or with from 1 to 4 ci-C3substituted heterocyclic five - or six-membered ring - alkyl groups, in each case up to two Contains oxygen atoms R5is hydrogen, methyl, ethyl, propyl, 1-Methylethyl, butyl, 1-methyl-propyl, 2 - Methylpropyl, 1.1-Dimethylethyl, CF3, CF2H, ccl3, C2F5, C3F7, CF (CF3)2; Acetyl, C2H5C (=O), C3H7C (=O), C4H9C (=O), cf3C (O), C2F5Q=O), ch3oc (=O), C2H5oc (=0), C3H7oc (O), C3H7oc (O), C4H9oc (O), cf3oc (O), ccl3oc (O), C2F5oc (O), CH2Och3; C2H4Och3, CH=CH2, CH2choh2, C H ≤ €, CH2C ≡ €H, SOCH3, soc2H5, soc3H7SO2CH3, SO2C2H5, SO2C3H7, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl; CH2ocf3; C2H4ocf3, C=ONH2, sime3, sime2 ZBu, sime2Ph X is nitrogen or CR8 Y is nitrogen or CR9 Z is nitrogen or CR10 wherein either Y and Z are equal to nitrogen, or Y is nitrogen and Z is equal to CR10is, OR Y is equal to CR9and Z is equal to nitrogen is hydrogen, fluorine, chlorine, bromine, iodine, cyano, hydroxy, OR11, O-Me, O-Et, O-Pr, O - / Pr, O Bu, O- secBu, O- isoBu, O - / Bu, och (CH3) CH2oh, och (CH3) CH2och3, och (C2H5) CH2oh, och (C2H5) CH2och3, O (CH2)2och3, O (CH2)2oh, O (CH2)3och3, O (CH2)3oh, ocf3, SR11, S-Me, S-Et, S-Pr, S-zpr, S-Bu, S- secBu, S- isoBu, S- ZBu, scf3, sor11, so-Me, so-Et, nh-Pr, so_l zpr, so-Bu, so_l secBu, so_l woBu, so_l ZBu, so2R11, SO2- Me, SO2- Et, SO2- Pr, SO2- Zpr, SO2- Bu, SO2- ^ ecBu, SO2- Wobu, SO2- Zbu, COR11, come, COEt, copr, COzPr, COBu, COsecBu, COZsoBu, COrBu, COCF3, CO2R11, CO2Me, CO2Et, CO2Pr, CO2Zpr, CO2Bu, CO ^ ecBu, CO2 Wobu, CO2 Zbu, CO2CH (CH3) CH2OH, CO2CH (CH3) CH2Och3, CO2CH (C2H5) CH2OH, CO2CH (C2H5) CH2Och3, CO2(CH2)2Och3, CO2(CH2)2OH, CO2(CH2)3Och3, CO2(CH2)3OH, NR11CO2R11, NR11CO2Me, NR11CO2Et, NR11CO2Pr, NR11CO2Zpr, NR11CO2Bu, NRuCO2 sedBu., NR11CO2 Wobu, NR11CO2 Zbu, NR11cor11, NR11come, NR11 COEt, NR11copr, NR11 COfPr, NR11 COBu, NRu COsecBu, NRu COwoBu, NR11 COzBu, methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methyl-propyl, 2 - methylpropyl, 1.1-Dimethylethyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2.2-Di-methyl-propyl, 1-Ethylpropyl, hexyl, 1.1-dimethylpropyl, 1.2-dimethylpropyl, 1 - Methylpentyl, 2-Methylpentyl, 3-Methylpentyl, 4-Methylpentyl, 1.1-dimethylbutyl, 1.2 - dimethylbutyl, 1.3-dimethylbutyl, 2.2-dimethylbutyl, 2.3-dimethylbutyl, 3.3 - dimethylbutyl, 1-Ethylbutyl, 2-Ethylbutyl, 1, 1, 2- Trimethylpropyl, 1, 2.2- Trimethylpropyl, 1 - ethyl - 1 - methyl-propyl and l-ethyl-2-propyl; CH2Och3, (CH2)2Och3, CH (CH3) CH2Och3, (CH2)2OH, CH (CH3) CH2OH, CF3, CF2H, ccl3, C2F5, C3F7, CF (CF3), Sime3, sime2 ZBu, sime2Ph, NHR11, N (R11^, nme2, net2, nhme, nh2, NHzBu, nhet, nhpr, NHzPr, NHBu, nh/Bu, NHsecBu, piperazine 1-yl, 4-methyl-piperazine-l-yl, Moφholin-1-yl, nhch (CH3) CH2OH, nhch (CH3) CH2Och3, nhch (C2H5) CH2OH, nhch (C2H5) CH2Och3, nh (CH2)2Och3, nh (CH2)2OH, nh (CH2)3Och3, nh (CH2)3OH, Nhac, NR11CH (CH3) CH2OH, NR11CH (CH3) CH2Och3, NR11CH (C2H5) CH2OH, NR11CH (C2H5) CH2Och3, NR1' (CHZ)2Och3, NR1^ CH2)ZOH, NR1 [(CH2)3Och3, NR1 CHz^)3OH, NR11Ac, NHCOEt, NHCOPr, NHCOZPr, NHCOBu, NHCOsecBu, NHCOwoBu, NHCOzBu, nhcocf3, nhcoc2F5, N (Me) zBu, N (Me) Et, N (Me) Pr, N (Me) zpr, N (Me) Bu, N (Me) secBu, N (Me) Z1Sobu, N (CH3) CH (CH3) CH2OH, N (CH3) CH (CH3) CH2Och3, N (CH3) CH (C2H5) CH2Oh, N (CH3) CH (C2H5) CH2Och3, N (CH3) (CH2)2Och3, N (CH3) (CH2)2Oh, N (CH3) (CH2)3Och3, N (CH3) (CH2)3Oh, nhcor11, nr11cor11, NMeAc, NMeCOEt, NMeCOPr, NMeCOZPr, NMeCOBu, NMeCOsecBu, ^ obus NMeCOZ, NMeCOzBu, NMeCOCF3, NMeCOC2F5, nhco2R11, nr11co2R11, nhco2Me, nhco2Et, nhco2Pr, nhco2Zpr, nhco2Bu, nhnhco2 secBu, NHCO2 ZsOBu, NHCO2 ZBu, NHCO2CF3, NHCO2C2F5, NHCO2ch (ch3) ch2OH, NHCO2ch (ch3) ch2Och3, NHCO2ch (C2H5) ch2OH, NHCO2ch (C2H5) ch2Och3, NHCO2(ch2)2Och3, NHCO2(ch2)2OH, NHCO2(ch2)3Och3, NHCO2(ch2)3OH, NMeCO2Me, NMeCO2Et, NMeCO2Pr, NMeCO2Zpr, NMeCO2Bu, ^ NMeCO ecBu, NMeCO2 Wobu, NMeCO2 ZBu, NMeCO2CF3, NMeCO2C2F5, NEtCO2Me, NEtCO2Et, NEtCO2Pr, NEtCO2Zpr, NEtCO2Bu, NEtCO2 secBu., NEtCO2 Uobu, NEtCO2 ZBu,  NEtCO2CF3, NEtCO2C2F5, SON (R11J2, SONHMe, SONMe2, SONHEt, sonet2, SONHPr, SONPr2, SONHBu, SONBu2, SONHCF3, SON (CF3)2, SO2N (R11^, SO2nhme, SO2nme2, SO2net2, SO2nhet, SO2npr2, SO2nhpr, SO2 NHCF3, SO2N (CF3)2, SO2nhch (ch3) ch2OH, SO2nhch (ch3) ch2Och3, SO2nhch (C2H5) ch2OH, SO2nhch (C2H5) ch2Och3, SO2nh (ch2)2Och3, SO2nh (ch2)2OH, SO2nh (ch2)3Och3, SO2NH (CH2)3OH, NHSOR11, NR11sor11, NHSOMe, NHSO2Me, NHSOEt, NHSO2Et, Nmesome, NHSO2R11, NR11SO2R11, Nmeso2Me, NMeSOEt, Nmeso2Et, NHSOCF3, NHSO2CF3, CON (Rπ)2, conh2, conhme, conme2, conhet, conet2, CO - morpholine, CO-alkyl-piperidine, CO-alkyl-piperazine, - C0 (4-methyl-piperazine), conhch (CH3) CH2OH, conhch (CH3) CH2Och3, conhch (C2H5) CH2OH, CONHCH (C2H5) ch2Och3, conh (ch2)2Och3, conh (ch2)2Oh, conh (ch2)3Och3, conh (ch2)3Oh, cyclopropyl, cyclopentyl, cyclohexyl, phenyl, pyridine-4-yl, pyridine-3 - yl, pyridine-2-yl, Thien-2-yl, Thien-3-yl, Furan-2-yl, Furan-3-yl, N-l, 3-oxazolidine 2-on, N - 4-methyl-l, 3-oxazolidine 2-on, N-4.4-dimethyl-l, 3-oxazolidine 2-on, N-4.5-dimethyl-l, 3 - oxazolidine-2-on, N-5.5-dimethyl-l, 3-oxazolidine 2-on, N-4-ethyl-l, 3-oxazolidine 2-on, - N 4.4-ethyl-l, 3-oxazolidine 2-on, hch Ν2tetrahydrofuran-2-yl R7is hydrogen, fluorine, chlorine, bromine, iodine, Cyano, hydroxy, amino, N (R1^2, nitro, Or11, Sr11, methyl, ethyl, propyl, 1-Methylethyl, butyl, 1-methyl-propyl, 2-Methylpropyl, 1.1 - Dimethylethyl, pentyl, 1-Methylbutyl, 2-Methylbutyl, 3-Methylbutyl, 2.2-Di-methyl-propyl, 1-Ethylpropyl, hexyl, 1.1-dimethylpropyl, 1.2-dimethylpropyl, l-Methylpentyl, 2 - Methylpentyl, 3-Methylpentyl, 4-Methylpentyl, 1.1-Dimethylbutyl, 1.2-Dimethylbutyl, 1.3-Dimethylbutyl, 2.2-Dimethylbutyl, 2.3-Dimethylbutyl, 3.3-Dimethylbutyl, 1 - Ethylbutyl, 2-Ethylbutyl, 1, 1, 2- Trimethylpropyl, 1, 2.2- Trimethylpropyl, 1 - ethyl - 1 - methyl-propyl and l-ethyl-2-methyl propyl; CF3, CF2H, ccl3, C2F5, C3F7, CF (CF3)2, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, sime3, coor1\ con (R1\ cor1' or R7and R10together form a saturated or unsaturated bridge of the following structure:  , ''R13 ^, ' R13 — N gt&amp;;; R13 \ =independently of one another hydrogen, fluorine, chlorine, bromine, iodine, methyl, ethyl, propyl, 1 - Methylethyl, CF2H, CF3, C2fs1Och3, Oc2H5, ocf3, Oc2F5or two residues R continuous geminally13represent doubly attached oxygen or sulphur. is hydrogen, fluorine, chlorine, bromine, iodine, Cyano, hydroxy, Nitro, OR11, O-Me, O-Et, O-Pr, O-Zpr, O-Bu, 0- secBu, O- Wobu, 0 - / Bu, - O (CH2)2oh, O - (CH2)2och3, O - (CH2)3oh, O - (CH2)3och3, ocf3, SR11, SH, S-Me, S-Et, S-Pr, S-Zpr, S-Bu, S- secBu, S- isoBu, S-tbu, scf3, sor11, so-Me, so-Et, nh-Pr, so_l ιPr, so-Bu, so_l secBu, so_l Wobu, S0-Φu, so2R11, so2- Me, so2- Et, so2- Pr, so2- Zpr, so2- Bu, so2- secBu., so2- Wobu, so2- ^ Bu, son (R1 ■), SONHMe, SONMe2, SONHEt, sonet2, SONHPr, SONPr2, SONHBu,  SONBu2, SONHCF3, SON (CF3)2, SO2N (RU)2, SO2nhme, SO2nme2, SO2net2, SO2nhet, SO2npr2, SO2nhpr, SO2 NHCF3, SO2N (CF3), cor11, come, COEt, copr, COzPr, COBu, COsecBu, COwoBu, COzBu, COCF3, nr11CO2R11, nr11CO2Me, nr11CO2Et, nr11CO2Pr, nr11CO2Zpr, nr11CO2Bu, nrπCO2 secBu, nr11CO2 Wobu, nr11CO2 Jbu, nr11cor11, nhcome, NHCOEt, NHCOPr, NHCOrPr, NHCOBu, NHCOZBu, NHCOsecBu,  NHCOZSoBu, NHCOZBu, NHCO (CH2)2OH, NHCO (CH2)2Och3, NHCO (CH2)3OH, NHCO (CH2)3Och3, NR11come, NR11 COEt, NR11copr, NR11 COZPr, NR11 COBu, NR11CO ^ Ru, NR11 COZSoBu, NR11 COZBu, NRnCO (CH2)2OH, NR11CO (CH2)ZOch3, NRπCO (CH2)3OH, NRnCO (CH2)3Och3, N (R1% nme2, net2, nhme, nh2, NHzBu, nhet, nhpr, NHZPr, NHBu, NHyecBu, NHZsoBu, 4-methyl-piperazine-l-yl, piperazine-1-yl, Morpholine 1-yl, NR11SO2R12, NHsor11, NR11sor11, NHSOMe, NHso2Me, NHSOEt, NHso2Et, Nmesome, NHso2R11, NR11SO2R11, Nmeso2Me, NMeSOEt, Nmeso2Et, NHSOCF3, NHso2CF3, OCON (R1')2, OCONHMe, OCONHEt, OCONHPr, OCONHZPr, OCONHBu, OCONHsecBu, OCONHZsoBu, OCONHzBu, OCONMe2, OCONEt2, OCONPr2, OCONZPr2, OCONBu2, OCONsecBu2, OCONZsoBu2, OCONzBu2, OCOr11, Ocome, OCOEt, OCOPr, OCOZPr, OCOBu, OCOsecBu, OCOZsoBu, OCOzBu, CON (R1%, conhet, conet2, conhme, conme2, CONHPr, CONPr2, CONHBu, OCONHBu, CONHZBu, conhch (CH3) CH2OH, conhch (CH3) CH2Och3, conhch (C2H5) CH2OH, conhch (C2H5) CH2Och3, conh (CH2)2Och3, conh (CH2)2OH, conh ( CHz)3Och3, conh (CH2)3OH, conr11CH (CH3) CH2OH, conr11CH (CH3) CH2Och3, conr11CH (C2H5) CH2OH, conr11CH (C2H5) CH2Och3, conr1 Vchz)2Och3, conr1 Vchz)2OH, conr1Vch2)JOch3, conr1' (CHJ)3OH, co2R11, co2Me, co2Et, co2Pr, co2Zpr, co2Bu, co2 yecBu., co2 woBu, co2fbu, co2(CH2)2OH, co2(CH2)2Och3, co2(CH2)3OH, co2(CH2)3Och3, (CH2)mOrn, CH2OH, (CH2)2OH, (CH2)3OH, ( CHz)4OH, CH2OMe, (CH2)2OMe, (CH2)3OMe, (CH2)4OMe, (CH2)mSRu, CH2SH, (CH2)2SH, (CH2)3SH, (CH2)4SH, CH2SMe, (CH2)2SMe, (CH2)3SMe, (CH2)4SMe, ( CHz)1nN (R1%, CH2nh2, CH2nac2, CH2N ( COCF3), CH2nhac, CH2nhcocf3, (CH2)2nh2, (CH2)3nh2, (CH2)4nh2, CH2nme2, (CH2)2nhme, ( CHz)2nme2, (CH2)3nhme, (CH2)3nme2, (CH2)4nhme, (CH2)4nme2, (CH2)mCOOr12, CH2coome, (CH2)2coome, (CH2)3coome, CH2cooet, (CH2)2cooet, (CH2)3cooet, CH2coopr, (CH2)2coopr, (CH2)3coopr, CH2 COOiPr, (CH2)2 COOZPr, (CH2)3COO/Pr, CH2 COOZBu, (CH2)2cootöu, (CH2)3COO * Bu, CH2COO (CH2)2OH CH2COO (CH2)2Och3,CH2COO (CH2)3OH, CH2COO (CH2)3Och3, CH2nhcoor11, CH2NR11coor11, CH2nhcoome, CH2 NHcooibu, CH2 NHCOOEt, CH2 NHcoopr, CH2 NHCOOZPr, CH2 NHCOOBu, CH2 NHCOOfBu, CH2 NHCOQϊ ecBu, CH2 NHCOOwoBu, CH2NR11COOEt, CH2NR11COOPr, CH2NR11 COOzTr, CH2NR11 COOBu, CH2NR11 COOZBu, CH2NR11 COOWOBU, methyl, ethyl, propyl, 1 - Methylethyl, butyl, 1 - methyl-propyl, 2-Methylpropyl, 1.1-Dimethylethyl, pentyl, 1 - Methylbutyl, 2-Methylbutyl, 3-Methylbutyl, 2.2-Di-methyl-propyl, 1-Ethylpropyl, hexyl, 1.1-Dimethylpropyl, 1.2-Dimethylpropyl, l-Methylpentyl, 2-Methylpentyl, 3-Methylpentyl, 4-Methylpentyl, 1.1-Dimethylbutyl, 1.2-Dimethylbutyl, 1.3-Dimethylbutyl, 2.2 - Dimethylbutyl, 2.3-Dimethylbutyl, 3.3-Dimethylbutyl, 1-Ethylbutyl, 2-Ethylbutyl, 1, 1, 2 - Trimethylpropyl, 1, 2, 2- Trimethylpropyl, 1 - ethyl - 1-methyl propyl and l-ethyl-2-methyl - propyl; cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl; CF3, CF2H, ccl3, C2F5, C3F7, CF (CF3), is hydrogen, fluorine, chlorine, bromine, iodine, N (R1')2, nme2, net2, nhme, nh2, NHrBu, nhet, nhpr, NHzPr, NHBu, NHsecBu, NHwoBu, 4-methyl-piperazine-l-yl, piperazine-1-yl, morpholine-1-yl, Cyano, hydroxy, or11, O-Me, O-Et, O-Pr, O - / Pr, O Bu, O- secBu, O - isoBu, O-tbu, - O (CH2)2oh, O - (CH2)2och3, O - (CH2)3oh, O - (CH2)3och3, ocf3, Sr11, SH, S-Me, S-Et, S-Pr, S-Zpr, S-Bu, S- secBu, S- isoBu, S-tbu, scf3, COR11, COme, COet, COpr, COfpr, CObu, COse1u, COisobu, COzbu, COCF3, methyl, ethyl, propyl, 1 - methylethyl, butyl, 1 - methyl-propyl, 2-methylpropyl, 1.1-Dimethylethyl, pentyl, 1 - methylbutyl, 2-methylbutyl, 3-methylbutyl, 2.2-Di-methyl-propyl, 1-ethylpropyl, hexyl, 1.1-dimethylpropyl, 1, 2-dimethylpropyl, 1 - methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-Methylpentyl, 1.1-Dimethylbutyl, 1.2-Dimethylbutyl, 1.3-Dimethylbutyl, 2, 2Dimethylbutyl, 2.3-Dimethylbutyl, 3.3-Dimethylbutyl, 1-Ethylbutyl, 2-Ethylbutyl, 1, 1, 2 - Trimethylpropyl, 1, 2, 2- Trimethylpropyl, 1-ethyl-l-methyl-propyl and l-ethyl-2-methyl - propyl; CF3, CF2H, ccl3, C2F5, C3F7, CF (CF3)2cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl R10is hydrogen, fluorine, chlorine, bromine, iodine, Cyano, hydroxy, amino, N (Rπ)2, nitro, Or11, Sr ", methyl, ethyl, propyl, 1-Methylethyl, butyl, 1-Methylpropyl, 2-Methylpropyl, 1.1 - Dimethylethyl, pentyl, 1-Methylbutyl, 2-Methylbutyl, 3-Methylbutyl, 2.2-Di-methyl-propyl, 1-Ethylpropyl, hexyl, 1.1-dimethylpropyl, 1.2-dimethylpropyl, l-Methylpentyl, 2 - Methylpentyl, 3-Methylpentyl, 4-Methylpentyl, 1.1-dimethylbutyl, 1.2-dimethylbutyl, 1.3-dimethylbutyl, 2.2-dimethylbutyl, 2.3-dimethylbutyl, 3.3-dimethylbutyl, 1 - Ethylbutyl, 2-Ethylbutyl, 1, 1, 2- Trimethylpropyl, 1, 2, 2- Trimethylpropyl, 1-ethyl-l - and l-ethyl-2-methyl propyl propyl; CF3, CF2H, ccl3, C2F5, C3F7, CF (CF3)2) cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, sime3, coor11, con (R1% R11is the same or different and are hydrogen, methyl, ethyl, propyl, 1-Methylethyl, butyl, 1 - Methylpropyl, 2-Methylpropyl, 1.1-Dimethylethyl, pentyl, 1-Methylbutyl, 2-Methylbutyl, 3-Methylbutyl, 2.2-Di-methyl-propyl, 1-Ethylpropyl, hexyl, 1.1-dimethylpropyl, 1.2 - dimethylpropyl, l-Methylpentyl, 2-Methylpentyl, 3-Methylpentyl, 4-Methylpentyl, 1.1 - dimethylbutyl, 1.2-dimethylbutyl, 1.3-dimethylbutyl, 2.2-dimethylbutyl, 2.3 - dimethylbutyl, 3.3-dimethylbutyl, 1-Ethylbutyl, 2-Ethylbutyl, 1, 1, 2- Trimethylpropyl, 1, 2, 2- Trimethylpropyl, 1-ethyl-l-methyl-propyl, l-ethyl-2-propyl, CH2CH2OMe, CH (CH3) CH2OMe, CH2CH (CH3) OMe, CH2CH2OEt, CH (CH3) CH2OEt, CH2CH (CH3) OEt, CF3, CF2H, ccl3, C2F5, C3F7, CF (CF3)2, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, sime3, phenyl or in the case, the two radicals R11bound to a nitrogen atom, two radicals R117-membered 3 to a, unsubstituted or substituted, saturated or unsaturated cycle, up to five further heteroatoms, selected from N, O and S may contain, where two oxygen atoms are not adjacent, form. or in the case, the two radicals R11adjacent in the grouping nr11Cor11are present, two radicals R117-membered 3 to a, unsubstituted or substituted, saturated or unsaturated cycle, up to five further heteroatoms, selected from N, O and S may contain, where two oxygen atoms are not adjacent to one, form. Ri2is methyl, ethyl, propyl, 1-Methylethyl, butyl, 1-Methylpropyl, 2-Methylpropyl, 1.1 - Dimethylethyl, pentyl, 1-Methylbutyl, 2-Methylbutyl, 3-Methylbutyl, 2.2-Di-methyl-propyl, 1-Ethylpropyl, hexyl, 1.1-dimethylpropyl, 1.2-dimethylpropyl, l-Methylpentyl, 2 - Methylpentyl, 3-Methylpentyl, 4-Methylpentyl, 1.1-Dimethylbutyl, 1.2-Dimethylbutyl, 1.3-Dimethylbutyl, 2.2-Dimethylbutyl, 2.3-Dimethylbutyl, 3.3-Dimethylbutyl, 1 - Ethylbutyl, 2-Ethylbutyl, 1, 1, 2- Trimethylpropyl, 1, 2.2- Trimethylpropyl, 1 - ethyl - 1 - methyl-propyl and l-ethyl-2-methyl propyl; CF3, CF2H, ccl3, C2F5, C3F7, CF (CF3)2, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, ch2OR11, (ch2)2ORπ, (ch2)3ORU, ( CHz)4OR1', sime3 and agrochemically active salts thereof as fungicides. 3. Use of compounds of formula (I) in which one or more of the symbols have the following meanings: R1to R4are independently hydrogen, fluorine, chlorine, bromine, iodine, Cyano, Hydroxy, Nitro, OR11, O-Me, O-Et, O-Pr, 0 - / Pr, O Bu, O- secBu, O- isoBu, O- Zbu, O - (CH2)2oh, O - (CH2)2och3, O - (CH2)3oh, O - (CH2)3och3, ocf3, SR11, SH, S-Me, S-Et, - Pr S, S-Zpr, S-Bu, S- secBu, S- isoBu, S-tbu, scf3, sor11, so-Me, so-Et, nh-Pr, so_l Zpr, so-Bu, so_l secBu, so_l isoBu, so_l Zbu, so2R11, so2- Me, so2- Et, so2- Pr, so2- Zpr, so2- Bu, so2- secBu., so2 Zsobu-, so2- Zbu, son (R1%, SONHMe, SONMe2, SONHEt, sonet2,  SONHPr, SONPr2, SONHBu, SONBu2, SONHCF3,SON (CF3)2, SO2N (R1%, SO2nhme, SO2nme2, SO2net2, SO2nhet, SO2npr2, SO2nhpr, SO2 NHCF3, SO2N (CF3), cor11, come, COEt, copr, COZPr, COBu, COsecBu, CO- isoBu, COzBu, COCF3, nr11CO2R11, nr11CO2Me, nr11CO2Et, nr11CO2Pr, nr11CO2Zpr, nr11CO2Bu, nr11CO2^ Ru, nr11CO2 ZWBU, nr11CO2 ZBU, nr11cor11, nhcome, NHCOEt, NHCOPr, NHCOZPr,  NHCOBu, NHCOZBu, NHCOsecBu, NHCOZwBu, NHCOZBu, NHCO (CH2)2OH, NHCO (CH2)2Och3, NHCO (CH2)3OH, NHCO (CH2)3Och3, NR11come, NR11 COEt, NR11copr, NR11 COZPr, NR11 COBu, NR11CO ^ 4u, NR11 COZBu, NR11CO ( CHz)2OH, NRUCO (CH2)2Och3, NRnCO (CH2)3OH, NRUCO (CH2)3Och3, N (RU)2, nme2, net2, nhme, nh2, NHzBu, nhet, nhpr, NHZPr, NHBu, NHzBu, NHsecBu, piperazine 1-yl, 4 - Methylpiperazine-1-yl, morpholine-lyl, NR11SO2R12, Nhsor11, NR11sor11, NHSOMe, Nhso2Me, NHSOEt, Nhso2Et, Nmesome, Nhso2R11, NR11SO2R11, Nmeso2Me, NMeSOEt, Nmeso2Et, NHSOCF3, Nhso2CF3, OCON (R11^, OCONHMe, OCONHEt, OCONHPr, OCONHZPr, OCONHBu, OCONHsecBu, OCONHZsoBu, OCONHzBu, OCONMe2, OCONEt2, OCONPr2, OCONiPr2, OCONBu2, OCONsecBu2, OCON UOBU2, OCONHJBU2, ocor11, ocome, OCOEt, OCOPr, OCOzTr, OCOBu, OCOsecBu, QCQisoBu, OCCMBu, CON (R1% conhet, conet2, conhme, conme2, CONHPr, CONPr2, CONHBu, CONHsecBu, CONHwoBu, CONHJBU, conhch (CH3) CH2OH, conhch (CH3) CH2Och3, conhch (C2H5) CH2OH, conhch (C2H5) CH2Och3, CONH (CH2)2Och3, CONH (CH2)2OH, CONH (CH2)3Och3, CONH (CH2)3OH, CONR11CH (CH3) CH2OH, CONR11CH (CH3) CH2Och3, CONR11CH (C2H5) CH2OH, CONR11CH (C2H5) CH2Och3, CONR1'(CHZ)2Och3, CONR1' (CHZ)2OH, CONR1 CHz^)3OCH3, CONR1 CHz^)3OH, CO2R11, CO2Me, CO2Et, CO2Pr, CO2 Jpr, CO2Bu, CO2ύ B \ i se, CO2 Wobu, CO2 Jbu, CO2(CH2)2OH, CO2(CH2)2OCH3, CO2(CH2)3OH, CO2( CHz)3OCH3, ( CHz)1nOR11, CH2OH, (CH2)2OH, (CH2)3OH, (CH2)4OH, CH2OMe, ( CHz)2OMe, ( CHz)3OMe, (CH2)4OMe, (CH2)mSRπ, CH2SH, (CH2)2SH, (CH2)3SH, (CH2)4SH, CH2SMe, (CH2)2SMe, (CH2)3SMe, (CH2)4SMe, (CH2)H1N (R11), CH2nh2, CH2nac2, CH2N ( COCF3)2, CH2nhac, CH2nhcocf3, (CH2)2nh2, (CH2)3nh2) ( CHz)4nh2, CH2nme2, ( CHz)2nhme, (CH2)2nme2, (CH2)3nhme, (CH2)3nme2, (CH2)4NHMe, (CH2)4NMe2, (CH2)mCOOR12, CH2coome, (CH2)2coome, (CH2)3coome, CH2cooet, (CH2)2cooet, (CH2)3cooet, CH2coopr, (CH2)2coopr, (CH2)3coopr, CH2 COOiPr, (CH2)2COO/Pr, (CH2)3COO * Pr, CH2 COOzBu, (CH2)2 COOJBu, (CH2)3COO/Bu, CH2COO (CH2)2OH CH2COO (CH2)2Och3,CH2COO (CH2)3OH, CH2COO (CH2)3Och3&amp;gt;CH2NHcoor11, CH2NR11COOR11, CH2NHCOOMe, CH2 NHCOOJBU, CH2 NHCOOEt, CH2 NHCOOPr, CH2 NHCOOzPr, CH2 NHCOOBu, CH2 NHCOOJBU, CH2nhcoourethane ϊ ecBu, CH2 NHCOOwoBu, CH2NR11COOEt, CH2NR11COOPr, CH2NR11 COOrPr, CH2NR11 COOBu, CH2NR11 COOJBu, Methyl, ethyl, propyl, 1-Methylethyl, butyl, 1 - methyl-propyl, 2-Methylpropyl, 1.1-Dimethylethyl, pentyl, 1-Methylbutyl, 2-Methylbutyl, 3-Methylbutyl, 2.2-Di-methyl-propyl, 1-Ethylpropyl, hexyl, 1.1-dimethylpropyl, 1.2 - dimethylpropyl, 1-Methylpentyl, 2-Methylpentyl, 3-Methylpentyl, 4-Methylpentyl, 1.1 - dimethylbutyl, 1, 2-dimethylbutyl, 1.3-dimethylbutyl, 2.2-dimethylbutyl, 2.3 - dimethylbutyl, 3.3-dimethylbutyl, 1-Ethylbutyl, 2-Ethylbutyl, 1, 1, 2- Trimethylpropyl, 1, 2, 2- Trimethylpropyl, 1 - ethyl - 1-methyl propyl and l-ethyl-2-methyl propyl; Cyclopropyl, Cyclobutyl, cyclopentyl, cyclohexyl; CF3, CF2H, ccl3, C2F5, C3F7, CF (CF3)2 in each case two adjacent radicals R1, R2or R2, R3or R3, R8or R8, R42.3-Dihydro-l together form a, - 4-dioxin, 2, 2, 3, 3-tetrafluoroethylene-2.3 Dihydro-l a, - 4-dioxin, a 1.3 - dioxole or 2.2-difluoro-l -, - 3-dioxole ring is hydrogen, Acetyl, trifluoroacetyl X is nitrogen or CR8 Y is nitrogen Z is nitrogen or CR10 R6is hydrogen, fluorine, chlorine, bromine, iodine, Cyano, hydroxy, or11, O-Me, O-Et, O-Pr, O - / Pr, O Bu, O- secBu, O- isoBu, O-tbu, och (CH3) CH2oh, och (CH3) CH2och3, OCH (C2H5) ch2oh, OCH (C2H5) ch2OCH3, O (ch2)2OCH3, O (ch2)2oh, O (ch2)3OCH3, O (ch2)3oh, ocf3, SR11, S-Me, S-Et, S-Pr, S-Zpr, S-Bu, S- secBu, S- isoBu, S-tbu, scf3, sor11, so-Me, so-Et, nh-Pr, so_l Zpr, so-Bu, so_l secBu, so_l Zsobu, so_l Zbu, so2R11, so2- Me, so2- Et, so2- Pr, so2- Zpr, so2- Bu, so2- lt&amp; . S ;? Ru, SO2- WoBu, SO2- ZBu, COR11, come, COEt, copr, COiPr, COBu, COsecBu, COisoBu, COzBu, COCF3, CO2R11, CO2Me, CO2Et, CO2Pr, CO2Zpr, CO2Bu, CO2 secBu, CO2 Wobu, CO2 Zbu, CO2CH (CH3) CH2OH, CO2CH (CH3) CH2Och3, CO2CH (C2H5) CH2OH, CO2CH (C2H5) CH2Och3, CO2(CH2)2Och3, CO2(CH2)2Oh, CO2(CH2)3Och3, CO2(CH2)3Oh, NR11CO2R11, NR11CO2Me, NR11CO2Et, NR11CO2Pr, NR11CO2Zpr, NR11CO2Bu, NR11CO2 SeRu, NR11CO2 Wobu, NR11CO2 Zbu, NR11cor11, NR11come, NR11 COEt, NR11copr, NR11 COZPr, NR11 COBu, NR11CO ^ Fu, NR11 COZJoBu, NR11 COZBu, Me, Et, Pr, Zpr, Bu, secBu, isoBu, Zbu, CH2Och3, (CH2)2Och3, CH (CH3) CH2Och3, (CH2)2OH, CH (CH3) CH2OH, CF3, CF2H, ccl3, C2F5, C3F7, CF (CF3)2 Sime3, sime2 ZBu, sime2Ph, NHR11, N (Rπ)2, nme2, net2, nhme, nh2, NHzBu, nhet, nhpr, NHZPr, NHBu, NHsecBu, NHZsoBu, nhch (CH3) CH2OH, nhch (CH3) CH2Och3, Is NHCH (C2H5) ch2Oh, NHCH (C2H5) ch2Och3, nh (ch2)2Och3, nh (ch2)2Oh, nh (ch2)3Och3, nh (ch2)3Oh, nhac, NR11ch (ch3) ch2Oh, NR11ch (ch3) ch2Och3, NR11ch (C2H5) ch2Oh, NR11ch (C2H5) ch2Och3, NR11 CCHz)2Och3, NR11cch ^2Oh, NRπ(ch2)3Och3, NR1 CHz^)3Oh, NR11Ac, NHCOEt, NHCOPr, NHCOZPr, NHCOBu, NHCOsecBu, ^ obus NHCOZ, NHCOzBu, nhcocf3, nhcoc2F5, N (Me) ZBu, N (Me) Et, N (Me) Pr, N (Me) zpr, N (Me) Bu, N (Me&amp;gt; ecBu, N (Me) Z ^ obus, N (CH3) CH (CH3) CH2OH, N (CH3) CH (CH3) CH2Och3, N (CH3) CH (C2H5) CH2OH, N (CH3) CH (C2H5) CH2Och3, N (CH3) (CH2)2Och3, N (CH3) (CH2)2OH, N (CH3) (CH2)3Och3, N (CH3) (CH2)3OH, nhcor11, nr1 1cor11, NMeAc, NMeCOEt, NMeCOPr, NMeCOZPr, NMeCOBu, NMeCOsecBu, ^ obus NMeCOZ, NMeCOzBu, NMeCOCF3, NMeCOC2F5, nhco2R1', NR11CO2R11, nhco2Me, nhco2Et, nhco2Pr, nhco2zpr, nhco2Bu, nhnhco2 secBu, nhco2Z ^ obus, nhco2 ZBu, nhco2CF3, nhco2C2F5, nhco2ch (ch3) ch2OH, nhco2ch (ch3) ch2Och3, nhco2ch (C2H5) ch2OH, nhco2ch (C2H5) ch2Och3, nhco2(ch2)2Och3, nhco2(ch2)2OH, nhco2(ch2)3Och3;nhco2(ch2)3OH, NMeCO2Me, NMeCO2Et, NMeCO2Pr, NMeCO2zpr, NMeCO2Bu, NMeCO2^ Ru, NMeCO2 Wobu, NMeCO2 ZBu, NMeCO2CF3, NMeCO2C2F5, NEtCO2Me, NEtCO2Et, NEtCO2Pr, NEtCO2zpr, NEtCO2Bu, NEtCO2^ Ru, NEtCO2 ZiOBu, NEtCO2 ZBu, NEtCO2CF3, NEtCO2C2F5, SON (R1^2, SONHMe, SONMe2, SONHEt, sonet2, SONHPr, SONPr2, SONHBu, SONBu2, SONHCF3,SON (CF3)2, SO2N (Rπ)2, SO2nhme, SO2nme2, SO2net2, SO2nhet, SO2npr2, SO2nhpr, SO2 NHCF3, SO2N (CF3), SO2nhch (CH3) CH2OH, SO2nhch (CH3) CH2Och3, SO2nhch (C2H5) CH2OH, SO2nhch (C2H5) CH2Och3, SO2nh (CH2)2Och3, SO2nh (CH2)2OH, SO2nh (CH2)3Och3, SO2nh (CH2)3OH, NHSOR11, nr11sor1', NHSOMe, NHSO2Me, NHSOEt, NHSO2Et, NMeSOMe, NHSO2R11, nr11SO2R11, NMeSO2Me, NMeSOEt, NMeSO2Et, NHSOCF3,  NHSO2CF3, CON (R1% conh2, conhme, conme2, conhet, conet2, CO - morpholine, CO-al(...)
法律状态
(WO200733780) LEGAL DETAILS FOR WO2007033780  Actual or expected expiration date=2009-03-24    Legal state=DEAD    Status=LAPSED     Event publication date=2006-09-12  Event code=WO/APP  Event indicator=Pos  Event type=Examination events  Application details  Application country=WO WOEP2006008861  Application date=2006-09-12  Standardized application number=2006WO-EP08861     Event publication date=2007-03-29  Event code=WO/A2  Event type=Examination events  International application published without international search report  Publication country=WO  Publication number=WO2007033780  Publication stage Code=A2  Publication date=2007-03-29  Standardized publication number=WO200733780     Event publication date=2007-10-11  Event code=WO/A3  Event indicator=Pos  Event type=Examination events  Later publication of ISR with revised front page  Publication country=WO  Publication number=WO2007033780  Publication stage Code=A3  Publication date=2007-10-11  Standardized publication number=WO200733780     Event publication date=2009-03-24  Event code=WO/EETL  Event type=Event indicating Not In Force  PCT Application validity period expired. LEGAL DETAILS FOR DESIGNATED STATE BRPI0617171  Actual or expected expiration date=2014-03-18    Legal state=DEAD    Status=LAPSED   Corresponding cc:  Designated or member state=BR Corresponding appl: BRPI0617171  Application date in the designated or member state=2006-09-12   Application number in the designated or member state=2006BR-0017171 Corresponding cc:  Designated or member state=BR Corresponding pat: BRPI0617171  Publication stage code in the designated or member state=A2  Publication date in the designated or member state=2011-07-12   Publication number in the designated or member state=BR200617171    Event publication date=2011-07-12  Event code=WO/ENP  Event type=Entry into national phase  Entry into the national phase in: Corresponding cc:  Designated or member state=BR   Effective date of the event=2008-03-24     Event publication date=2014-08-05  Event code=BR/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=BR  LEGAL DETAILS FOR DESIGNATED STATE CA2623267  Actual or expected expiration date=2013-09-12    Legal state=DEAD    Status=LAPSED   Corresponding cc:  Designated or member state=CA Corresponding appl: CA2623267  Application date in the designated or member state=2006-09-12   Application number in the designated or member state=2006CA-2623267 Corresponding cc:  Designated or member state=CA Corresponding pat: CA2623267  Publication stage code in the designated or member state=A1  Publication date in the designated or member state=2007-03-29   Publication number in the designated or member state=CA2623267    Event publication date=2008-03-20  Event code=WO/WWE  Event indicator=Pos  Event type=Entry into national phase  Wipo information: entry into national phase Corresponding cc:  Designated or member state=CA     Event publication date=2013-11-07  Event code=CA/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=CA  LEGAL DETAILS FOR DESIGNATED STATE CN101309586  Actual or expected expiration date=2012-11-14    Legal state=DEAD    Status=LAPSED   Corresponding cc:  Designated or member state=CN Corresponding appl: CN200680042889  Application date in the designated or member state=2006-09-12   Application number in the designated or member state=2006CN-80042889 Corresponding cc:  Designated or member state=CN Corresponding pat: CN101309586  Publication stage code in the designated or member state=A  Publication date in the designated or member state=2008-11-19   Publication number in the designated or member state=CN101309586    Event publication date=2012-11-14  Event code=CN/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=CN  LEGAL DETAILS FOR DESIGNATED STATE DE  Actual or expected expiration date=2008-03-26    Legal state=DEAD    Status=LAPSED   Corresponding cc:  Designated or member state=DE     Event publication date=2008-03-26  Event code=WO/NENP  Event type=Event indicating Not In Force  Non-entry into the national phase in: Corresponding cc:  Designated or member state=DE  LEGAL DETAILS FOR DESIGNATED STATE EA200800848  Actual or expected expiration date=2013-10-30    Legal state=DEAD    Status=LAPSED   Corresponding cc:  Designated or member state=EA Corresponding appl: EA200800848  Application date in the designated or member state=2006-09-12   Application number in the designated or member state=2008EA-0000848 Corresponding cc:  Designated or member state=EA Corresponding pat: EA200800848  Publication stage code in the designated or member state=A1  Publication date in the designated or member state=2008-10-30   Publication number in the designated or member state=EA200800848    Event publication date=2008-10-30  Event code=EA/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=EA  LEGAL DETAILS FOR DESIGNATED STATE EP1928243  Actual or expected expiration date=2011-10-20    Legal state=DEAD    Status=LAPSED   Corresponding cc:  Designated or member state=EP Corresponding appl: EP06777187  Application date in the designated or member state=2006-09-12   Application number in the designated or member state=2006EP-0777187 Corresponding cc:  Designated or member state=EP Corresponding pat: EP1928243  Publication stage code in the designated or member state=A2  Publication date in the designated or member state=2008-06-11   Publication number in the designated or member state=EP1928243    Event publication date=2007-07-04  Event code=WO/121  Event type=Designated states  EP: The EPO has been informed by wipo that ep was designated in this application Corresponding cc:  Designated or member state=EP     Event publication date=2008-03-14  Event code=WO/WWE  Event indicator=Pos  Event type=Entry into national phase  Wipo information: entry into national phase Corresponding cc:  Designated or member state=EP     Event publication date=2008-06-11  Event code=WO/WWP  Event indicator=Pos  Event type=Examination events  Wipo information: published in national office Corresponding cc:  Designated or member state=EP     Event publication date=2011-11-23  Event code=EP/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=EP  LEGAL DETAILS FOR DESIGNATED STATE IL190207  Actual or expected expiration date=2013-11-03    Legal state=DEAD    Status=LAPSED   Corresponding cc:  Designated or member state=IL Corresponding appl: IL19020708  Application date in the designated or member state=2006-09-12   Application number in the designated or member state=2006IL-0190207 Corresponding cc:  Designated or member state=IL Corresponding pat: IL190207  Publication stage code in the designated or member state=A  Publication date in the designated or member state=2008-11-03   Publication number in the designated or member state=IL-190207    Event publication date=2008-03-17  Event code=WO/WWE  Event indicator=Pos  Event type=Entry into national phase  Wipo information: entry into national phase Corresponding cc:  Designated or member state=IL     Event publication date=2008-11-03  Event code=IL/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=IL  LEGAL DETAILS FOR DESIGNATED STATE JP2009508891  Actual or expected expiration date=2011-10-31    Legal state=DEAD    Status=LAPSED   Corresponding cc:  Designated or member state=JP Corresponding appl: JP2008531575  Application date in the designated or member state=2006-09-12   Application number in the designated or member state=2008JP-0531575 Corresponding cc:  Designated or member state=JP Corresponding pat: JP2009508891  Publication stage code in the designated or member state=A  Publication date in the designated or member state=2009-03-05   Publication number in the designated or member state=JP2009508891    Event publication date=2008-03-21  Event code=WO/WWE  Event indicator=Pos  Event type=Entry into national phase  Wipo information: entry into national phase Corresponding cc:  Designated or member state=JP     Event publication date=2011-11-01  Event code=JP/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=JP  LEGAL DETAILS FOR DESIGNATED STATE KR20080049844  Actual or expected expiration date=2013-08-30    Legal state=DEAD    Status=REVOKED   Corresponding cc:  Designated or member state=KR Corresponding appl: KR20087009600  Application date in the designated or member state=2008-04-22   Application number in the designated or member state=2008KR-7009600 Corresponding cc:  Designated or member state=KR Corresponding pat: KR20080049844  Publication stage code in the designated or member state=A  Publication date in the designated or member state=2008-06-04   Publication number in the designated or member state=KR20080049844    Event publication date=2013-08-30  Event code=KR/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=KR  LEGAL DETAILS FOR DESIGNATED STATE MX  Actual or expected expiration date=2026-09-12    Legal state=ALIVE    Status=PENDING   Corresponding cc:  Designated or member state=MX Corresponding appl: MXMX/a/2008/003929    Event publication date=2008-03-24  Event code=WO/WWE  Event indicator=Pos  Event type=Entry into national phase  Wipo information: entry into national phase Corresponding cc:  Designated or member state=MX  LEGAL DETAILS FOR DESIGNATED STATE US2009030024  Actual or expected expiration date=2012-01-12    Legal state=DEAD    Status=LAPSED   Corresponding cc:  Designated or member state=US Corresponding appl: US6763406  Application date in the designated or member state=2006-09-12   Application number in the designated or member state=2006US-12067634 Corresponding cc:  Designated or member state=US Corresponding pat: US2009030024  Publication stage code in the designated or member state=A1  Publication date in the designated or member state=2009-01-29   Publication number in the designated or member state=US20090030024    Event publication date=2008-07-16  Event code=WO/WWE  Event indicator=Pos  Event type=Entry into national phase  Wipo information: entry into national phase Corresponding cc:  Designated or member state=US     Event publication date=2012-01-12  Event code=US/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=US
专利类型码
A2A3
国别省市代码
若您需要申请原文,请登录。

最新评论

暂无评论。

登录后可以发表评论

意见反馈
返回顶部